XML 60 R52.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Revenue Recognition - Additional Information (Details)
3 Months Ended 10 Months Ended 12 Months Ended
Mar. 07, 2019
Segment
Dec. 31, 2019
USD ($)
Sep. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Sep. 30, 2018
USD ($)
Jun. 30, 2018
USD ($)
Mar. 31, 2018
USD ($)
Dec. 31, 2019
USD ($)
Segment
Dec. 31, 2019
USD ($)
Segment
Program
Obligation
Source
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Disaggregation Of Revenue [Line Items]                          
Number of reportable segments | Segment 1                 2 2    
Revenue, Practical Expedient, Initial Application and Transition, Qualitative Assessment                     true    
Revenue   $ 272,789,000 [1] $ 303,897,000 $ 340,377,000 $ 214,094,000 $ 153,037,000 [2] $ 151,467,000 $ 151,865,000 $ 149,930,000   $ 1,131,157,000 [3] $ 606,299,000 $ 556,942,000
Healthcare                          
Disaggregation Of Revenue [Line Items]                          
Number of programs | Program                     3    
Number of performance obligations | Obligation                     1    
Number of performance obligation unsatisfied | Obligation                     0    
Revenue recognized from performance obligations satisfied in prior period                     $ 0    
Period of billing in arrears once timing of services to customers is known                     1 month    
Number of days for customer to make payment after being invoiced                     30 days    
Capitalized costs   500,000       $ 0       $ 500,000 $ 500,000 0  
Capitalized costs, amortized                       0 $ 0
Number of reportable segments | Segment                     2    
Revenue                     $ 633,066,000 $ 606,299,000  
Nutrition                          
Disaggregation Of Revenue [Line Items]                          
Number of sources for revenue recognition | Source                     4    
Description of return of obligation                     Direct to consumer customers may return unopened ready-to-go Nutrisystem products within 30 days after purchase in order to receive a refund or credit.    
Return of purchase order to refund or credit, period                     30 days    
Purchase order canceled of delivery, period                     14 days    
Revenue                     $ 498,091,000    
Provision for estimated returns                     13,500,000    
Nutrition | Accrued Liabilities                          
Disaggregation Of Revenue [Line Items]                          
Reserve for estimated returns   $ 800,000               $ 800,000 800,000    
Nutrition | Shipping and Handling Charges                          
Disaggregation Of Revenue [Line Items]                          
Revenue                     $ 17,500,000    
[1] During the fourth quarter of 2019, we recorded an impairment loss of $377.1 million related to the Nutrisystem tradename and the goodwill allocated to the Nutrition segment.  In addition, we incurred acquisition, integration, and project costs totaling $5.8 million, which were primarily recorded to selling, general, and administrative expenses (see Note 18 for full year amounts).  Also in the fourth quarter of 2019, we recorded a purchase accounting measurement period adjustment to finalize estimates related to the customer list intangible asset recorded in connection with the acquisition of Nutrisystem.  The finalization of the estimate resulted in incremental amortization expense during the fourth quarter of 2019 of $17.4 million. Our effective tax rate for the fourth quarter of 2019 was a benefit of 15.2%, which was less than our statutory tax benefit rate and represents a decrease compared to the first three quarters of 2019.  This decrease is primarily due to the nondeductible goodwill impairment loss of $137.1 million recorded in the fourth quarter. Finally, the impact of potentially dilutive securities for the three months ended December 31, 2019 was not considered because the impact would be anti-dilutive.
[2] During the fourth quarter of 2018, we incurred $3.3 million of project costs in connection with potential and pending acquisitions, which were recorded to selling, general, and administrative expenses.  In addition, our effective tax rate for the fourth quarter of 2018 of 10.1% was lower than our statutory rate primarily due to positive tax benefits of $4.6 million related to the vesting of stock-based compensation awards during the quarter.
[3] The figure for total segments equals the consolidated figure for each such item.